524414
NORRIS
Start SIP
Invest Now
Start SIP in NORRIS
Performance
- Low
- ₹15
- High
- ₹15
- 52 Week Low
- ₹14
- 52 Week High
- ₹25
- Open Price₹15
- Previous Close₹15
- Volume500
Investment Returns
- Over 1 Month -9.52%
- Over 3 Month -6.75%
- Over 6 Month -26.63%
- Over 1 Year -35.09%
Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!
Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9.7
- PEG Ratio
- 0.1
- Market Cap Cr
- 15
- P/B Ratio
- Average True Range
- 1
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.31
- RSI
- 46.36
- MFI
- 36.49
Norris Medicines Financials
Norris Medicines Technicals
EMA & SMA
Current Price
₹14.93
-0.07
(-0.47%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹15.27
- 50 Day
- ₹15.78
- 100 Day
- ₹16.34
- 200 Day
- ₹16.93
Resistance and Support
14.88
- R3 16.97
- R2 16.23
- R1 15.62
- S1 14.27
- S2 13.53
- S3 12.92
Norris Medicines Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-13 | Quarterly Results & Others | Inter-alia, to consider 1. Requests from Mr. Nimish Bhishma Thakore, for reclassification from Promoter / Promoter Group into Public Category. 2. Other business matters. |
| 2024-11-14 | Quarterly Results |
Norris Medicines F&O
About Norris Medicines
- NSE Symbol
- NORRIS
- BSE Symbol
- 524414
- ISIN
- INE744C01029
Similar Stocks to Norris Medicines
Norris Medicines FAQs
Norris Medicines share price is ₹14 As on 09 December, 2025 | 10:12
The Market Cap of Norris Medicines is ₹14.9 Cr As on 09 December, 2025 | 10:12
The P/E ratio of Norris Medicines is -9.7 As on 09 December, 2025 | 10:12
The PB ratio of Norris Medicines is -1 As on 09 December, 2025 | 10:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.